Myocardial infarction in ANCA-associated vasculitis: a population-based cohort study

Myocardial infarction in ANCA-associated vasculitis: a population-based cohort study

Objectives To determine the incidence rate (IR) and predictors of myocardial infarction (MI) in patients with antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) as well as to estimate the IR ratio (IRR) of MI in AAV versus the background population.Methods 325 patients diagno...

Full description

Saved in:

Bibliographic Details
Main Authors:	Moman Aladdin Mohammad, David Jayne, David Erlinge, Aladdin J Mohammad, Jens Rathmann, Ylva Borgas, Karl Gisslander
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-04-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/11/2/e005055.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Epidemiology and clinical characteristics of biopsy-confirmed adult-onset IgA vasculitis in southern Sweden
by: David Jayne, et al.
Published: (2024-02-01)

Comparison of different ANCA detection methods in a predominantly MPO-ANCA-associated vasculitis cohort
by: Yasuhiro Katsumata, et al.
Published: (2025-01-01)

Thrombosis risk factors in ANCA-associated vasculitis
by: E. N. Kharlamova, et al.
Published: (2023-04-01)

Treatment With Avacopan in ANCA–Associated Vasculitis With Kidney Involvement
by: Duvuru Geetha, et al.
Published: (2025-08-01)

Comorbid infections in patients with ANCA-associated systemic vasculitis: a prospective cohort study
by: M. A. Litvinova, et al.
Published: (2025-04-01)

Endothelial dysfunction of vessels at ANCA-associated systemic vasculitis
by: L. V. Sedaia, et al.
Published: (2015-08-01)

The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
by: Atulya Aman Khosla, et al.
Published: (2023-01-01)

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

Burden of coronary artery calcification in ANCA-associated vasculitis
by: Claire Cook, et al.
Published: (2025-01-01)

Case report: Testicular manifestation of ANCA vasculitis
by: Noah J. Sandel, et al.
Published: (2025-03-01)

PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS
by: T. V. Beketova, et al.
Published: (2016-12-01)

ANCA-Associated Vasculitis after Moderna COVID-19 Vaccination
by: Shiko Gen, et al.
Published: (2023-01-01)

Practical Management of ANCA-Associated Vasculitis: A Clinician’s Perspective
by: Hannah L. Stacey, et al.
Published: (2024-12-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

Fulminant Vasculitis Complicated by ST-Elevation Myocardial Infarction and Stroke
by: Vy A. Pham, et al.
Published: (2021-01-01)

Exploring ANCA Pathogenicity in Ulcerative Colitis: A Case Report Highlighting the Risk of Progression to ANCA-Associated Vasculitis
by: Abir Hamid, et al.
Published: (2025-05-01)

Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2021-12-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

Successful total hip arthroplasty in patients with anca-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2019-11-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis
by: T. V. Beketova
Published: (2023-10-01)

Prospective study of complications and sequelae of glucocorticoid therapy in ANCA-associated vasculitis
by: Bernhard Hellmich, et al.
Published: (2024-02-01)

The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis
by: Erik Hellbacher, et al.
Published: (2025-06-01)

Incidence and prevalence of ANCA-associated vasculitis in Oslo, Norway, applying different criteria-based case definitions: a population-based cohort study
by: Øyvind Molberg, et al.
Published: (2025-07-01)

A case report of metastatic renal cell carcinoma and ANCA associated vasculitis
by: Maddison Taylor, et al.
Published: (2025-07-01)

Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy
by: van Leeuwen JR, et al.
Published: (2025-01-01)

Goodpasture’s Syndrome and p-ANCA Associated Vasculitis in a Patient of Silicosiderosis: An Unusual Association
by: Amanjit Bal, et al.
Published: (2014-01-01)

ANCA Vasculitis and Hemophagocytic Lymphohistiocytosis following a Fecal Microbiota Transplant
by: Adam Amlani, et al.
Published: (2018-01-01)

WCN24-1407 CLINICAL PANORAMA OF ANCA ASSOCIATED VASCULITIS IN A RURAL LOW-INCOME POPULATION OF LATIN AMERICA
by: PAULA VIOLETA RODRIGUEZ SEGURA, et al.
Published: (2024-04-01)

Risk factors of poor outcomes in ANCA-associated vasculitis: a single-center study
by: Axi Age, et al.
Published: (2025-12-01)

Propylthiouracil-induced ANCA-associated vasculitis complicated by granulocytopenia and hemophagocytosis: a case report
by: Huilin Zhou, et al.
Published: (2025-04-01)

Integrated bioinformatic analysis of the shared molecular mechanisms between ANCA-associated vasculitis and atherosclerosis
by: Xun Hu, et al.
Published: (2024-12-01)

Imbalance of Circulatory T Follicular Helper and T Follicular Regulatory Cells in Patients with ANCA-Associated Vasculitis
by: Ying Xu, et al.
Published: (2019-01-01)

WCN25-1022 LONG-TERM KIDNEY FUNCTION BEYOND 12 MONTHS AND KIDNEY RELAPSE AFTER INITIATION OF TREATMENT FOR ANCA-ASSOCIATED VASCULITIS
by: Lisa Uchida, et al.
Published: (2025-02-01)

Monocyte Chemoattractant Protein 1 is a Prognostic Marker in ANCA-Associated Small Vessel Vasculitis
by: Sophie Ohlsson, et al.
Published: (2009-01-01)

Pulmonary and Renal Predictors of Mortality in ANCA-Associated Vasculitis: A Regional Experience from Türkiye
by: Dilara Bulut Gökten, et al.
Published: (2025-06-01)

Use of Avacopan as a Steroid-Sparing Medication in ANCA-associated Vasculitis Patients with Renal Impairment
by: Mitchell Salke, et al.
Published: (2025-06-01)

Disease Activity and Tendency to Relapse in ANCA-Associated Vasculitis Are Reflected in Neutrophil and Intermediate Monocyte Frequencies
by: Sofia Smargianaki, et al.
Published: (2024-01-01)

Development of a Nomogram Model to Predict Mortality in ANCA‐Associated Vasculitis Patients With Pulmonary Involvement
by: Qifang Guo, et al.
Published: (2025-04-01)

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)